Kyungsoo Ha

Osong Medical Innovation Foundation — South Korea

Medicine · Health Sciences

20h-index2.1kcitations69works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cytokine Signaling Pathways and Interactions(9), Myeloproliferative Neoplasms: Diagnosis and Treatment(9), DNA Repair Mechanisms(8), Heat shock proteins research(8), Monoclonal and Polyclonal Antibodies Research(7)

Publications69 total

Tumor-priming CD8+ natural killer T-like cells as an efficient novel cell therapy for relapsed/refractory multiple myeloma
Experimental Hematology and Oncology·2025Open Access
Nanobody-Based CAR NK Cells for Possible Immunotherapy of Mesothelin<sup>+</sup> Tumors
Immune Network·2025· 5 citedOpen Access
Assessing the predictive ability of computational epitope prediction methods on Fel d 1 and other allergens
PLoS ONE·2024· 1 citedOpen Access
Pan-cancer analysis reveals multifaceted roles of retrotransposon-fusion RNAs
2023· 2 citedOpen Access
Assessing the predictive ability of computational epitope prediction methods on Fel d 1 and other allergens
2023· 1 citedOpen Access
Abstract 1122: Pan-cancer analysis reveals roles of retrotransposon-fusion RNAs
Cancer Research·2023· 1 cited
Supplementary Figure 1 from Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy against Triple-Negative Human Breast Cancer Cells
2023Open Access
Data from Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy against Triple-Negative Human Breast Cancer Cells
2023Open Access
Supplementary Figures Legends 1-4 from Hsp90 Inhibitor–Mediated Disruption of Chaperone Association of ATR with Hsp90 Sensitizes Cancer Cells to DNA Damage
2023Open Access
Data from Hsp90 Inhibitor–Mediated Disruption of Chaperone Association of ATR with Hsp90 Sensitizes Cancer Cells to DNA Damage
2023Open Access
Supplementary Figures 1-4 from Hsp90 Inhibitor–Mediated Disruption of Chaperone Association of ATR with Hsp90 Sensitizes Cancer Cells to DNA Damage
2023Open Access
Data from Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy against Triple-Negative Human Breast Cancer Cells
2023Open Access
Supplementary Figures 1-4 from Hsp90 Inhibitor–Mediated Disruption of Chaperone Association of ATR with Hsp90 Sensitizes Cancer Cells to DNA Damage
2023Open Access
Supplementary Figure 1 from Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy against Triple-Negative Human Breast Cancer Cells
2023Open Access
Supplementary Figures Legends 1-4 from Hsp90 Inhibitor–Mediated Disruption of Chaperone Association of ATR with Hsp90 Sensitizes Cancer Cells to DNA Damage
2023Open Access
Data from Hsp90 Inhibitor–Mediated Disruption of Chaperone Association of ATR with Hsp90 Sensitizes Cancer Cells to DNA Damage
2023Open Access
Data from Heat Shock Protein 90 Inhibitor Is Synergistic with JAK2 Inhibitor and Overcomes Resistance to JAK2-TKI in Human Myeloproliferative Neoplasm Cells
2023Open Access
Supplemental Methods from SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents
2023Open Access
Supplemental Figures 1-5 from SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents
2023Open Access
Figures 1-4 from Heat Shock Protein 90 Inhibitor Is Synergistic with JAK2 Inhibitor and Overcomes Resistance to JAK2-TKI in Human Myeloproliferative Neoplasm Cells
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Kapil N. Bhalla(23), Warren Fiskus(22), Ramesh Balusu(15), Sreedhar Venkannagari(13), Veena Coothankandaswamy(8), Rekha Rao(8), Hyung‐Goo Kim(7), Ari Melnick(7), Rekha Rao(7), Stacey L. Hembruff(7), Jianguang Chen(7), Jacqueline E. Smith(6), Peter Atadja(6), Dyana T. Saenz(6), Stephanie Krieger(6), Christopher P. Mill(6), Peng Huang(6), Jeff S. Mumm(6), Uma Mudunuru(5), Hongwei Ma(5)